Table 3.
Demographic and clinical characteristics of patients whose oculomotor tests were consistent and inconsistent with the MRI findings (n = 75).
| Variables | Consistent n = 44 |
Inconsistent n = 31 |
p-Value |
|---|---|---|---|
| Median age at diagnosis, | * <0.001 | ||
| years (IQR) | 55 (41.5–63.5) | 69 (52–76) | |
| Gender | 0.968 | ||
| Female | 30 (68.2%) | 21 (67.7%) | |
| Male | 14 (31.8%) | 10 (32.3%) | |
| Body mass index | 0.378 | ||
| Median (IQR) | 23.2 (20.6–25.5) | 24.0 (21.8–25.9) | |
| Asymmetric hearing loss | 0.804 | ||
| No | 33 (86.8%) | 24 (88.9%) | |
| Yes (>30 dB loss) | 5 (13.2%) | 3 (11.1%) | |
| Neurologic symptoms | 0.640 | ||
| No | 36 (81.4%) | 24 (77.4%) | |
| Yes | 8 (18.6%) | 7 (22.6%) | |
| Central lesions (MRI) | 0.478 | ||
| No | 34 (77.3%) | 26 (83.9%) | |
| Yes | 10 (22.7%) | 5 (16.1%) | |
| Lesion sites (MRI) | 0.327 | ||
| Cortical and subcortical | 3 (27.3%) | 1 (20.0%) | |
| Brain stem | 6 (54.6%) | 1 (20.0%) | |
| Cerebellar | 2 (18.1%) | 3 (60.0%) | |
| Lesion types (MRI) | 0.213 | ||
| Cerebrovascular accident | 7 (70.0%) | 2 (40.0%) | |
| Tumors | 3 (30.0%) | 1 (20.0%) | |
| Inflammation | 0 (0.0%) | 2 (40.0%) | |
| Comorbidities | |||
| Diabetes mellitus | 0.468 | ||
| No | 37 (84.1%) | 24 (77.4%) | |
| Yes | 7 (15.9%) | 7 (22.6%) | |
| Hypertension | 0.204 | ||
| No | 25 (56.8%) | 13 (41.9%) | |
| Yes | 19 (43.2%) | 18 (58.1%) | |
| Hyperlipidemia | 0.240 | ||
| No | 30 (68.2%) | 17 (54.8%) | |
| Yes | 14 (31.8%) | 14 (45.2%) | |
| History of CVA | 0.067 | ||
| No | 43 (97.7%) | 27 (87.1%) | |
| Yes | 1 (2.3%) | 4 (12.9%) | |
| Cardiovascular disease | 0.160 | ||
| No | 43 (97.7%) | 28 (90.3%) | |
| Yes | 1 (2.3%) | 3 (9.7%) | |
| Accumulated comorbidities | * 0.017 | ||
| 0 | 15 (34.1%) | 3 (9.7%) | |
| 1–2 | 27 (61.3%) | 23 (74.2%) | |
| ≥3 | 2 (4.6%) | 5 (16.1%) |
* p < 0.05. Abbreviations: CVA, cerebrovascular accident; IQR, interquartile range.